🇺🇸 Vancomycin capsules in United States

14 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 14

Most-reported reactions

1. Drug Ineffective — 3 reports (21.43%)
2. Abdominal Pain — 2 reports (14.29%)
3. Product Physical Issue — 2 reports (14.29%)
4. Anal Incontinence — 1 report (7.14%)
5. Ascites — 1 report (7.14%)
6. Clostridium Difficile Infection — 1 report (7.14%)
7. Condition Aggravated — 1 report (7.14%)
8. Death — 1 report (7.14%)
9. Diarrhoea — 1 report (7.14%)
10. Drug Effect Decreased — 1 report (7.14%)

Source database →

Frequently asked questions

Is Vancomycin capsules approved in United States?

Vancomycin capsules does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Vancomycin capsules in United States?

Astellas Pharma Europe B.V. is the originator. The local marketing authorisation holder may differ — check the official source linked above.